Mrdc contract DHA sbir sequential PH II covid-19 pivot proposal no. H2S-0017 titled ultra-high concentration protein delivery formulation technology for the rapid deployment of treatments of…

Ended Definitive Contract Awarded Last action

Contract number
W81XWH21C0079
Awardee
Awarding agency
Obligated
$1,499,982

Award facts

Opportunity
  • HQ003420R1DSB Solicitation number
Contract value 100% obligated
$1,499,981.51 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Defense Health Agency Department of Defense
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Boston, MA 02210, USA
Research
SBIR Program Phase II Action

Award details come from SAM.gov/FPDS.

About this award

Elektrofi, Inc. was awarded a firm fixed price definitive contract valued at $1.5 million by the Defense Health Agency (DHA) to support Phase II of its Small Business Innovation Research (SBIR) program. The contract calls for Elektrofi to deliver its ultra-high concentration protein delivery formulation technology to rapidly deploy treatments for COVID-19 and future pandemics. Research will be conducted in Boston, Massachusetts over a two-year period concluding in November 2023. The award was made through DHA's SBIR sequential Phase II proposal solicitation and has a total small business set aside designation.

Description

Mrdc contract DHA sbir sequential PH II covid-19 pivot proposal no. H2S-0017 titled ultra-high concentration protein delivery formulation technology for the rapid deployment of treatments of covid-19 and future pandemics

Quick answers

Who was awarded contract W81XWH21C0079?

W81XWH21C0079 was awarded to Elektrofi, Inc. by Medical Command (Department of the Army) on July 2, 2021.

How much is contract W81XWH21C0079 worth?

The government has obligated $1,499,982 on W81XWH21C0079.

Which agency awarded contract W81XWH21C0079?

Medical Command (Department of the Army) awarded W81XWH21C0079, with funding from Defense Health Agency (Department of Defense).

Was contract W81XWH21C0079 competed?

The extent of competition for W81XWH21C0079 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award